Meta facebook tracking pixel

Listen Now

Topics Covered

  • The Treatment of Triple Negative Breast Cancer
  • Why Clinical Trials Are Important as a Treatment Option for Triple Negative Breast Cancer
  • What Happens in a Clinical Trial
  • Stages of Clinical Trials
  • New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
  • Investigational New Drugs in Clinical Trials
  • The Meaning of Informed Consent
  • Benefits & Risks of Participation
  • How & Where Clinical Trials are Conducted
  • How to Participate in Clinical Trials
  • Specific Questions to Ask Your Health Care Team about Clinical Trials
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions & Discussion of OpenNotes
  • Accessing Resources for Clinical Trials
  • Questions for Our Panel of Experts

Our Panel of Experts


Antoinette R. Tan, MD, MHSc, FACP, FASCO

Chief, Section of Breast Medical Oncology, Director, Phase I Program, Chair, Department of Solid Tumor Oncology and Investigational Therapeutics; Levine Cancer Institute; Clinical Professor, Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine; Atrium Health


Wade Smith, MD

Breast Cancer Specialist, Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Newport Beach, California


Melissa Berry

Board Chair, Triple Negative Breast Cancer Foundation®; Triple Negative Breast Cancer Thriver; Founder, Cancer Fashionista


Marissa Fors, MSW

Director of Specialized Programs, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on January 10, 2024.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.